Bachem Holding AG (LON: 0QND)
London
· Delayed Price · Currency is GBP · Price in CHF
59.40
-0.35 (-0.59%)
Jan 23, 2025, 2:16 PM BST
Bachem Holding AG Revenue
Bachem Holding AG had revenue of 240.31M CHF in the half year ending June 30, 2024, with 2.31% growth. This brings the company's revenue in the last twelve months to 577.77M, up 7.65% year-over-year. In the year 2023, Bachem Holding AG had annual revenue of 577.32M with 8.57% growth.
Revenue (ttm)
577.77M CHF
Revenue Growth
+7.65%
P/S Ratio
n/a
Revenue / Employee
288.02K CHF
Employees
2,006
Market Cap
4.01B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 577.32M | 45.58M | 8.57% |
Dec 31, 2022 | 531.74M | 28.51M | 5.66% |
Dec 31, 2021 | 503.23M | 101.24M | 25.18% |
Dec 31, 2020 | 402.00M | 88.28M | 28.14% |
Dec 31, 2019 | 313.72M | 31.22M | 11.05% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |